![Xi-Yong Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xi-Yong Fu
Plus aucun poste en cours
Fortune : 539 513 $ au 31/07/2026
Profil
Xi-Yong Fu was the founder of RVAC Medicines Pte Ltd., founded in 2021, and held the title of Chief Executive Officer from 2021 to 2024.
Dr. Fu is also the founder of RVAC Medicines..
Dr. Fu was Chief Executive Officer at Abio-X Holdings, Inc. Dr. Fu was Chief Executive Officer & Director at NovaBridge Biosciences from 2024 to 2026.
Dr. Fu earned an MBA from the University of Pennsylvania and a doctorate from The Ohio State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVABRIDGE BIOSCIENCES 0,41 % | 24/03/2026 | 775 698 ( 0,41 % ) | 539 513 $ | 31/07/2026 |
Anciens postes connus de Xi-Yong Fu
| Sociétés | Poste | Fin |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur Général | 30/06/2026 |
RVAC Medicines Pte Ltd.
 RVAC Medicines Pte Ltd. Internet Software/ServicesTechnology Services Develops mRNA platform company | Directeur Général | 01/02/2024 |
RVAC Medicines
 RVAC Medicines Pharmaceuticals: MajorHealth Technology Operates as a mRNA platform company | Fondateur | - |
Abio-X Holdings, Inc. | Directeur Général | - |
Formation de Xi-Yong Fu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
RVAC Medicines Pte Ltd.
RVAC Medicines Pte Ltd. Internet Software/ServicesTechnology Services Develops mRNA platform company | Technology Services |
RVAC Medicines
RVAC Medicines Pharmaceuticals: MajorHealth Technology Operates as a mRNA platform company | Health Technology |
Abio-X Holdings, Inc. |
